Semaglutide has emerged as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and suppressing glucagon https://zubairvsnm144619.affiliatblogger.com/87780257/understanding-semaglutide-a-comprehensive-guide